Inventor

HERGENROTHER PAUL J

US57 patents

⚠️ This page may combine multiple inventors who share the name “HERGENROTHER PAUL J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HERGENROTHER PAUL J

UNIV ILLINOIS

Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs

Procaspase-activating compounds and compositions

Substituted piperazinyl acetohydrazide procaspase-activating compounds

Potent anticancer activity via dual compound activation

Enzyme-activating compounds and compositions

PAC-1 combination therapy

Compositions and methods including cell death inducers and procaspase activation

Therapeutic methods and agents for treating myotonic dystrophy

Therapeutic methods and agents for treating myotonic dystrophy

Procaspase activating compounds

Cancer therapy by degrading dual MEK signaling

Procaspase 3 activation by combination therapy

Procaspase combination therapy for glioblastoma

PAC-1 combination therapy

Compounds and anti-tumor NQO1 substrates

Activators of the unfolded protein response

Topoisomerase inhibitors with antibacterial and anticancer activity

Small molecules active against gram-negative bacteria

Cancer therapy by degrading dual MEK signaling

Procaspase combination therapy for glioblastoma

PAC-1 combination therapy

Procaspase combination therapy for glioblastoma

Procaspase 3 activation by combination therapy

Compounds and methods for the treatment of cancer

Procaspase combination therapy for glioblastoma

Procaspase 3 activation by combination therapy

Activators of the unfolded protein response

Activators of the unfolded protein response

Small molecules active against gram-negative bacteria

Combination therapy for the treatment of uveal melanoma

Saliva-based molecular testing for SARS-CoV-2

Saliva-based molecular testing for SARS-CoV-2

Procaspase-activating compounds and methods

Procaspase-activating compounds and methods

Small molecules that induce intrinsic pathway apoptosis

Compounds and anti-tumor NQO1 substrates

Compounds and methods for the treatment of cancer

Compounds and anti-tumor NQO1 substrates

Ribocil C antibiotics effective for Gram-negative pathogens

Antibiotics effective for gram-negative pathogens

HERGENROTHER PAUL J

Compositions and methods including cell death inducers and procaspase activation

Procaspase 3 activation by combination therapy

Procaspase combination therapy for glioblastoma

Compounds and anti-tumor NQO1 substrates

MASSACHUSETTS INST TECHNOLOGY

Compounds, compositions and methods of agelastatin alkaloids

Compounds, compositions and methods of agelastatin alkaloids

Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment

Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment

UNIV ALABAMA

Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells

UNIV TEXAS

Tumor-selective combination therapy